285 related articles for article (PubMed ID: 37143677)
1. Identification of gut dysbiosis in axial spondyloarthritis patients and improvement of experimental ankylosing spondyloarthritis by microbiome-derived butyrate with immune-modulating function.
Min HK; Na HS; Jhun J; Lee SY; Choi SS; Park GE; Lee JS; Um IG; Lee SY; Seo H; Shin TS; Kim YK; Lee JJ; Kwok SK; Cho ML; Park SH
Front Immunol; 2023; 14():1096565. PubMed ID: 37143677
[TBL] [Abstract][Full Text] [Related]
2. Axial spondyloarthritis patients have altered mucosal IgA response to oral and fecal microbiota.
Gill T; Stauffer P; Asquith M; Laderas T; Martin TM; Davin S; Schleisman M; Ramirez C; Ogle K; Lindquist I; Nguyen J; Planck SR; Shaut C; Diamond S; Rosenbaum JT; Karstens L
Front Immunol; 2022; 13():965634. PubMed ID: 36248884
[TBL] [Abstract][Full Text] [Related]
3. Gut dysbiosis associated with worse disease activity and physical function in axial spondyloarthritis.
Sagard J; Olofsson T; Mogard E; Marsal J; Andréasson K; Geijer M; Kristensen LE; Lindqvist E; Wallman JK
Arthritis Res Ther; 2022 Feb; 24(1):42. PubMed ID: 35151357
[TBL] [Abstract][Full Text] [Related]
4. Reduced Abundance of Butyrate-Producing Bacteria Species in the Fecal Microbial Community in Crohn's Disease.
Takahashi K; Nishida A; Fujimoto T; Fujii M; Shioya M; Imaeda H; Inatomi O; Bamba S; Sugimoto M; Andoh A
Digestion; 2016; 93(1):59-65. PubMed ID: 26789999
[TBL] [Abstract][Full Text] [Related]
5. Faecal microbiota study reveals specific dysbiosis in spondyloarthritis.
Breban M; Tap J; Leboime A; Said-Nahal R; Langella P; Chiocchia G; Furet JP; Sokol H
Ann Rheum Dis; 2017 Sep; 76(9):1614-1622. PubMed ID: 28606969
[TBL] [Abstract][Full Text] [Related]
6. Faecalibacterium prausnitzii subspecies-level dysbiosis in the human gut microbiome underlying atopic dermatitis.
Song H; Yoo Y; Hwang J; Na YC; Kim HS
J Allergy Clin Immunol; 2016 Mar; 137(3):852-60. PubMed ID: 26431583
[TBL] [Abstract][Full Text] [Related]
7. Faecalibacterium prausnitzii Produces Butyrate to Maintain Th17/Treg Balance and to Ameliorate Colorectal Colitis by Inhibiting Histone Deacetylase 1.
Zhou L; Zhang M; Wang Y; Dorfman RG; Liu H; Yu T; Chen X; Tang D; Xu L; Yin Y; Pan Y; Zhou Q; Zhou Y; Yu C
Inflamm Bowel Dis; 2018 Aug; 24(9):1926-1940. PubMed ID: 29796620
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-15 promotes intestinal dysbiosis with butyrate deficiency associated with increased susceptibility to colitis.
Meisel M; Mayassi T; Fehlner-Peach H; Koval JC; O'Brien SL; Hinterleitner R; Lesko K; Kim S; Bouziat R; Chen L; Weber CR; Mazmanian SK; Jabri B; Antonopoulos DA
ISME J; 2017 Jan; 11(1):15-30. PubMed ID: 27648810
[TBL] [Abstract][Full Text] [Related]
9. Gut Inflammation in Axial Spondyloarthritis Patients is Characterized by a Marked Type 17 Skewed Mucosal Innate-like T Cell Signature.
Mortier C; Quintelier K; De Craemer AS; Renson T; Deroo L; Dumas E; Verheugen E; Coudenys J; Decruy T; Lukasik Z; Van Gassen S; Saeys Y; Hoorens A; Lobatón T; Van den Bosch F; Van de Wiele T; Venken K; Elewaut D
Arthritis Rheumatol; 2023 Nov; 75(11):1969-1982. PubMed ID: 37293832
[TBL] [Abstract][Full Text] [Related]
10. Multi 'Omics Analysis of Intestinal Tissue in Ankylosing Spondylitis Identifies Alterations in the Tryptophan Metabolism Pathway.
Berlinberg AJ; Regner EH; Stahly A; Brar A; Reisz JA; Gerich ME; Fennimore BP; Scott FI; Freeman AE; Kuhn KA
Front Immunol; 2021; 12():587119. PubMed ID: 33746944
[TBL] [Abstract][Full Text] [Related]
11. Measurement of pre-treatment inflammatory cytokine levels is valuable for prediction of treatment efficacy to tumor necrosis factor inhibitor in axial spondyloarthritis patients.
Peng F; Chen F; Wen H; Bai J; Tian Y
Int J Rheum Dis; 2022 Aug; 25(8):844-850. PubMed ID: 35694730
[TBL] [Abstract][Full Text] [Related]
12. No Significant Effects of IL-23 on Initiating and Perpetuating the Axial Spondyloarthritis: The Reasons for the Failure of IL-23 Inhibitors.
Zhang H; Jiang HL; Dai SM
Front Immunol; 2022; 13():818413. PubMed ID: 35222393
[TBL] [Abstract][Full Text] [Related]
13.
Wang X; Li Y; Wang X; Wang R; Hao Y; Ren F; Wang P; Fang B
Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674791
[TBL] [Abstract][Full Text] [Related]
14. Age and fecal microbial strain-specific differences in patients with spondyloarthritis.
Stoll ML; Weiss PF; Weiss JE; Nigrovic PA; Edelheit BS; Bridges SL; Danila MI; Spencer CH; Punaro MG; Schikler K; Reiff A; Kumar R; Cron RQ; Morrow CD; Lefkowitz EJ
Arthritis Res Ther; 2018 Jan; 20(1):14. PubMed ID: 29382366
[TBL] [Abstract][Full Text] [Related]
15. Randomized double-blinded controlled trial on the effect of synbiotic supplementation on IL-17/IL-23 pathway and disease activity in patients with axial spondyloarthritis.
Ahangari Maleki M; Malek Mahdavi A; Soltani-Zangbar MS; Yousefi M; Khabbazi A
Immunopharmacol Immunotoxicol; 2023 Feb; 45(1):43-51. PubMed ID: 35947039
[TBL] [Abstract][Full Text] [Related]
16. Functional intraepithelial lymphocyte changes in inflammatory bowel disease and spondyloarthritis have disease specific correlations with intestinal microbiota.
Regner EH; Ohri N; Stahly A; Gerich ME; Fennimore BP; Ir D; Jubair WK; Görg C; Siebert J; Robertson CE; Caplan L; Frank DN; Kuhn KA
Arthritis Res Ther; 2018 Jul; 20(1):149. PubMed ID: 30029674
[TBL] [Abstract][Full Text] [Related]
17. T cells in the pathogenesis of axial spondyloarthritis.
Rosine N; Fogel O; Koturan S; Rogge L; Bianchi E; Miceli-Richard C
Joint Bone Spine; 2023 Dec; 90(6):105619. PubMed ID: 37487956
[TBL] [Abstract][Full Text] [Related]
18. Low abundance of colonic butyrate-producing bacteria in HIV infection is associated with microbial translocation and immune activation.
Dillon SM; Kibbie J; Lee EJ; Guo K; Santiago ML; Austin GL; Gianella S; Landay AL; Donovan AM; Frank DN; McCARTER MD; Wilson CC
AIDS; 2017 Feb; 31(4):511-521. PubMed ID: 28002063
[TBL] [Abstract][Full Text] [Related]
19. A reduction in the butyrate producing species Roseburia spp. and Faecalibacterium prausnitzii is associated with chronic kidney disease progression.
Jiang S; Xie S; Lv D; Zhang Y; Deng J; Zeng L; Chen Y
Antonie Van Leeuwenhoek; 2016 Oct; 109(10):1389-96. PubMed ID: 27431681
[TBL] [Abstract][Full Text] [Related]
20. Management of Axial Spondyloarthritis - Insights into Upadacitinib.
Braun J; Kiltz U; Baraliakos X
Drug Des Devel Ther; 2022; 16():3609-3620. PubMed ID: 36268520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
